Want to see AU:SHG full AI Analyst Report?
SHG Stock Chart & Stats
AU$0.26
AU$0.03(15.38%)
At close: 4:00 PM EST
AU$0.26
AU$0.03(15.38%)
Day’s Range― - ―
52-Week RangeAU$0.17 - AU$0.41
Previous CloseN/A
Volume808.83K
Average Volume (3M)1.03M
Market Cap
AU$57.82M
Enterprise ValueAU$60.72M
Total Cash (Recent Filing)AU$11.06M
Total Debt (Recent Filing)AU$113.71K
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding321,201,900
10 Day Avg. Volume889,327
30 Day Avg. Volume1,029,223
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)6.82
Price to Sales (P/S)160.16
P/FCF Ratio-37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported Leverage (2025)The 2025 balance sheet shows zero debt and a large equity base, reducing near-term refinancing risk and providing financial flexibility. For the next 2-6 months this strengthens the company’s ability to fund operations or pursue strategic options without immediate debt pressure.
Predictable Cash-burn RelationshipFree cash flow moving roughly in line with net losses creates a predictable burn profile, aiding financial planning and runway estimates. This predictability helps management size capital raises and target cost reductions more effectively over a multi-month horizon.
Lean Operating HeadcountAn eight-person headcount implies low fixed personnel overhead and operational agility. With few employees, management can adjust cost levels more quickly, preserving cash runway and enabling focused product or go-to-market adjustments over the coming months.
Bears Say
Persistent UnprofitabilityConsistent losses and a negative gross profit in 2025 signal structural unprofitability. This undermines internal funding capacity, forces reliance on external capital, and limits the company's ability to reinvest in growth or scale margins absent a sustained change in revenue or cost structure.
Chronic Negative Cash GenerationOperating and free cash flow have been negative each year and FCF worsened in 2025, indicating ongoing cash burn. Over 2-6 months this elevates funding and execution risk, making future product development or commercialization contingent on new financing or rapid cash conservation.
Sharp, Recent Revenue DeclineA ~36% revenue drop in 2025 after prior growth indicates unstable top-line performance and potential demand or execution issues. This weakens prospects for margin recovery and increases the likelihood of further restructuring or dilution if revenue stabilization is not achieved.
Singular Health Group Ltd News
SHG FAQ
What was Singular Health Group Ltd’s price range in the past 12 months?
Singular Health Group Ltd lowest share price was AU$0.17 and its highest was AU$0.41 in the past 12 months.
What is Singular Health Group Ltd’s market cap?
Singular Health Group Ltd’s market cap is AU$57.82M.
When is Singular Health Group Ltd’s upcoming earnings report date?
Singular Health Group Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 58 days.
How were Singular Health Group Ltd’s earnings last quarter?
Singular Health Group Ltd released its earnings results on Feb 23, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.01.
Is Singular Health Group Ltd overvalued?
According to Wall Street analysts Singular Health Group Ltd’s price is currently Overvalued.
Does Singular Health Group Ltd pay dividends?
Singular Health Group Ltd does not currently pay dividends.
What is Singular Health Group Ltd’s EPS estimate?
Singular Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Singular Health Group Ltd have?
Singular Health Group Ltd has 321,201,900 shares outstanding.
What happened to Singular Health Group Ltd’s price movement after its last earnings report?
Singular Health Group Ltd reported an EPS of -AU$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of Singular Health Group Ltd?
Currently, no hedge funds are holding shares in AU:SHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Singular Health Group Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:SHG Sentiment 97%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
252.94%
12-Months-Change
Fundamentals
Return on Equity
-59.96%
Trailing 12-Months
Asset Growth
145.48%
Trailing 12-Months
Company Description
Singular Health Group Ltd
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.
Technical Analysis
Mach7 Technologies
―
Beamtree Holdings Ltd
―
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---








